A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The p53 tumor suppressor gene is mutated in about half of human cancers, but the p53 pathway is thought to be functionally inactivated in the vast majority of cancer. Understanding how tumor cells can become insensitive to p53 activation is therefore of major importance. Using an RNAi-based genetic screen, we have identified three novel genes that regulate p53 function. RESULTS: We have screened the NKI shRNA library targeting 8,000 human genes to identify modulators of p53 function. Using the shRNA barcode technique we were able to quickly identify active shRNA vectors from a complex mixture. Validation of the screening results indicates that the shRNA barcode technique can reliable identify active shRNA vectors from a complex pool. Using this approach we have identified three genes, ARNTL, RBCK1 and TNIP1, previously unknown to regulate p53 function. Importantly, ARNTL (BMAL1) is an established component of the circadian regulatory network. The latter finding adds to recent observations that link circadian rhythm to the cell cycle and cancer. We show that cells having suppressed ARNTL are unable to arrest upon p53 activation associated with an inability to activate the p53 target gene p21(CIP1). CONCLUSIONS: We identified three new regulators of the p53 pathway through a functional genetic screen. The identification of the circadian core component ARNTL strengthens the link between circadian rhythm and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 1×
“inhibits MDM2, the major E3 ubiquitin ligase for p53”
BackgroundRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 2×
“The G1 phase cell cycle arrest is p53 dependent and mainly executed by the CDK inhibitor p21 [31,32] .”
BackgroundMethodMice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · cited 1×
“leading to stabilization and activation of p53. Activation of p53 leads to transcriptional activation of a large set of p53 target genes, which in turn causes cell cycle arrest or apoptosis”
BackgroundBerns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Mop3 is an essential component of the master circadian pacemaker in mammals.
Bunger, M. K., Wilsbacher, L. D., Moran, S. M., Clendenin, C., Radcliffe, L. A., Hogenesch, J. B., Simon, M. C., Takahashi, J. S., & Bradfield, C. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00205-1 · Cited by 1,621
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Interacting molecular loops in the mammalian circadian clock
Shearman, L. P., Sriram, S., Weaver, D. R., Maywood, E. S., Chaves, I., Zheng, B., Kume, K., Lee, C. C., van der, G. T. J., Horst, et al. (2000) · Science · doi:10.1126/science.288.5468.1013 · Cited by 1,367 · cited 1×
“Target genes of the CLOCK/ARNTL heterodimer include the Period 1, 2 and 3 and Cryptochromes (Cry 1 & 2) [46].”
BackgroundRegulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
Kondratov, R. V., Kondratova, A. A., Gorbacheva, V. Y., Vykhovanets, O. V., & Antoch, M. P. (2006) · Genes & Development · doi:10.1101/gad.1432206 · Cited by 1,188 · cited 1×
“In addition, the ARNTL knockout mouse also suffers from premature aging [44].”
BackgroundMammalian circadian biology: elucidating genome-wide levels of temporal organization
Lowrey, P. L., & Takahashi, J. S. (2004) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.5.061903.175925 · Cited by 976
p53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., et al. (2006) · Nature Methods · doi:10.1038/nmeth854 · Cited by 920
The circadian clock: pacemaker and tumour suppressor
Fu, L., & Lee, C. C. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1072 · Cited by 678 · cited 2×
“Recently multiple reports have discussed the relationship between cancer and circadian rhythm [24–26].”
BackgroundGery, S., Komatsu, N., Baldjyan, L., Yu, A., Koo, D., & Koeffler, H. P. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.038 · Cited by 630
Identification of the ubiquitin–protein ligase that recognizes oxidized IRP2
Yamanaka, K., Ishikawa, H., Megumi, Y., Tokunaga, F., Kanie, M., Rouault, T. A., Morishima, I., Minato, N., Ishimori, K., & Iwai, K. (2003) · Nature Cell Biology · doi:10.1038/ncb952 · Cited by 181 · cited 1×
“The other three genes, ARNTL [20], RBCK1 [21] and TNIP1 [22] have not been linked to p53 before.”
Background
Research works printed but not linked: 30
- KH Vousden, 2007, p53 in health and disease., Nat Rev Mol Cell Biol, 8, 275, 10.1038/nrm2147 · DOI · Paper page
- S Chuikov, 2004, Regulation of p53 activity through lysine methylation., Nature, 432, 353, 10.1038/nature03117 · DOI · Paper page
- CL Brooks, 2003, Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation., Curr Opin Cell Biol, 15, 164, 10.1016/S0955-0674(03)00003-6 · DOI · Paper page
- W Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain., Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
- K Berns, 2004, A large-scale RNAi screen in human cells identifies new components of the p53 pathway., Nature, 428, 431, 10.1038/nature02371 · DOI · Paper page
- TR Brummelkamp, 2006, An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors., Nat Chem Biol, 2, 202, 10.1038/nchembio774 · DOI · Paper page
- R Bernards, 2006, shRNA libraries and their use in cancer genetics., Nat Methods, 3, 701, 10.1038/nmeth921 · DOI
- VN Ngo, 2006, A loss-of-function RNA interference screen for molecular targets in cancer., Nature, 441, 106, 10.1038/nature04687 · DOI · Paper page
- JM Silva, 2008, Profiling essential genes in human mammary cells by multiplex RNAi screening., Science, 319, 617, 10.1126/science.1149185 · DOI · Paper page
- MR Schlabach, 2008, Cancer proliferation gene discovery through functional genomics., Science, 319, 620, 10.1126/science.1149200 · DOI · Paper page
- CJ Echeverri, 2006, Minimizing the risk of reporting false positives in large-scale RNAi screens., Nat Methods, 3, 777, 10.1038/nmeth1006-777 · DOI · Paper page
- K Heyninck, 1999, The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN., J Cell Biol, 145, 1471, 10.1083/jcb.145.7.1471 · DOI · Paper page
- WS el-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression., Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
- L Fu, 2002, The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo., Cell, 111, 41, 10.1016/S0092-8674(02)00961-3 · DOI · Paper page
- S Panda, 2002, Circadian rhythms from flies to human., Nature, 417, 329, 10.1038/417329a · DOI · Paper page
- N Gekakis, 1998, Role of the CLOCK protein in the mammalian circadian mechanism., Science, 280, 1564, 10.1126/science.280.5369.1564 · DOI · Paper page
- S Panda, 2002, Coordinated transcription of key pathways in the mouse by the circadian clock., Cell, 109, 307, 10.1016/S0092-8674(02)00722-5 · DOI · Paper page
- CJ Sherr, 2006, Divorcing ARF and p53: an unsettled case., Nat Rev Cancer, 6, 663, 10.1038/nrc1954 · DOI · Paper page
- X Qian, 2008, Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer., Int J Cancer, 122, 1400, 10.1002/ijc.23243 · DOI
- M Ocker, 2007, Histone deacetylase inhibitors: signalling towards p21cip1/waf1., Int J Biochem Cell Biol, 39, 1367, 10.1016/j.biocel.2007.03.001 · DOI · Paper page
- G Lagger, 2003, The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene., Mol Cell Biol, 23, 2669, 10.1128/MCB.23.8.2669-2679.2003 · DOI · Paper page
- AL Gartel, 2001, Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3., Proc Natl Acad Sci U S A, 98, 4510, 10.1073/pnas.081074898 · DOI · Paper page
- K Heyninck, 2003, Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1., FEBS Lett, 536, 135, 10.1016/S0014-5793(03)00041-3 · DOI · Paper page
- J Bayle, 2006, The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins., FEBS Lett, 580, 2609, 10.1016/j.febslet.2006.03.093 · DOI
- T Kirisako, 2006, A ubiquitin ligase complex assembles linear polyubiquitin chains., Embo J, 25, 4877, 10.1038/sj.emboj.7601360 · DOI · Paper page
- Y Tian, 2007, RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation., J Biol Chem, 282, 16776, 10.1074/jbc.M701913200 · DOI · Paper page
- K Tatematsu, 2005, Nuclear-cytoplasmic shuttling of a RING-IBR protein RBCK1 and its functional interaction with nuclear body proteins., J Biol Chem, 280, 22937, 10.1074/jbc.M413476200 · DOI
- T Matsuo, 2003, Control mechanism of the circadian clock for timing of cell division in vivo., Science, 302, 255, 10.1126/science.1086271 · DOI · Paper page
- MW Young, 2001, Time zones: a comparative genetics of circadian clocks., Nat Rev Genet, 2, 702, 10.1038/35088576 · DOI · Paper page
- A Grechez-Cassiau, 2008, The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation., J Biol Chem, 283, 4535, 10.1074/jbc.M705576200 · DOI · Paper page
Cited by
Circadian Rhythm Disruption Promotes Lung Tumorigenesis
Papagiannakopoulos, T., Bauer, M. R., Davidson, S. M., Heimann, M., Subbaraj, L., Bhutkar, A., Bartlebaugh, J., Vander Heiden, M. G., & Jacks, T. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.001 · Cited by 557
“Interestingly however, there was no increase in tumor burden in KP tumors with conditional Bmal1 (Bmal1Δ/Δ) loss (Figure S2A), suggesting a possible p53-dependent role for Bmal1 as has been suggested by a prior study (Mullenders et al., 2009).”
Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment
Sulli, G., Lam, M. T. Y., & Panda, S. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.07.002 · Cited by 480
A Genome-wide RNAi Screen for Modifiers of the Circadian Clock in Human Cells
Zhang, E. E., Liu, A. C., Hirota, T., Miraglia, L. J., Welch, G., Pongsawakul, P. Y., Liu, X., Atwood, A., Huss, J. W., Janes, J., et al. (2009) · Cell · doi:10.1016/j.cell.2009.08.031 · Cited by 431
Circadian clock control of the cellular response to DNA damage
Sancar, A., Lindsey-Boltz, L. A., Kang, T.-H., Reardon, J. T., Lee, J. H., & Ozturk, N. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.017 · Cited by 319
Genomic Screening with RNAi: Results and Challenges
Mohr, S., Bakal, C., & Perrimon, N. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060408-092949 · Cited by 282
Metadata
- Authors
- Mullenders, J., Fabius, A. W. M., Madiredjo, M., Bernards, R., & Beijersbergen, R. L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-03-11
- Volume
- 4
- Issue
- 3
- Pages
- e4798
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2016397316
- Cited by
- 144
- References
- 17
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.